LATEST NEWS:
Meet us at the ASCO Annual Meeting; booth #3100
Remaining sponsor benefits with last-minute discount
European CME credits and ESMO-MORA points granted
WIN Consortium leaders’ view on the WIN 2013 Symposium now on ecancer.org
Details of symposium dinner online now; tickets still available
Reserve your discounted hotel room in Paris now!
==============================================
The WIN 2013 Symposium is the fifth in an annual series of multi-sector, worldwide Symposia dedicated to the advancement of personalized cancer medicine. The theme of WIN2013, taking place July 10-12, 2013, in Paris, France, is:
“Personalized Cancer Therapy: From Innovation to Implementation”
Join leaders from around the world in a collaborative, global forum to learn about and share innovations that represent the most promising advances in personalized cancer care. Globally-recognized experts from academia, pharma, life-sciences, healthcare IT, and regulatory agencies will present in plenary sessions on:
- OMICS assays that support personalized clinical care today
Moderator: Alexander Eggermont, Institut Gustave Roussy (France) - Analysis and clinical application of genomics
Moderator: Levi Garraway, Dana-Farber Cancer Institute (USA) - Clinical progress in personalized cancer therapy
Moderator: Richard L. Schilsky, ASCO (USA) - New approaches that impact personalized cancer care
Moderator: John Mendelsohn, MD Anderson Cancer Center (USA)
WIN2013 is a unique opportunity for all stakeholders in personalized cancer medicine. With extended time for discussion and interaction, the Symposium offers you opportunities to learn from, and network with, leaders from around the globe regarding the most transformational developments in cancer care.
The WIN Symposium series is an initiative of the Worldwide Innovative Networking (WIN) Consortium, a global collaboration of leading academic, industry, and advocacy organizations created to accelerate the pace and reduce the cost of translating the most promising innovations in personalized cancer medicine into the standard of care worldwide.
“The annual WIN Symposium in Paris provides a unique opportunity for leading stakeholders from academia,
industry, government and advocacy groups in genomic cancer medicine to present data, exchange ideas
and develop new research collaborations.”
- John Mendelsohn, Chairman, WIN Consortium -
Download presentations from WIN 2012 sessions
Organizing Committee
John Mendelsohn
Director, Khalifa Institute of Personalized Cancer Medicine and
Past-President, MD Anderson Cancer Center (USA)
Alexander Eggermont
Director General
Institut Gustave Roussy (France)
Richard L. Schilsky
Professor Emeritus, University of Chicago
Chief Medical Officer, ASCO (USA)
Gerald Batist
Chairman, Oncology and Director, McGill Centre
for Translational Research in Cancer
McGill University (Canada)
Vladimir Lazar
Chief Operating Officer
WIN Consortium (France)
Catherine Bresson
Director, Operational Team
WIN Consortium (France)
